My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 320

    1.

    Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.

    Wang LF, Fokas E, Juricko J, You A, Rose F, Pagenstecher A, Engenhart-Cabillic R, An HX.

    BMC Cancer. 2008 Mar 25;8:79.PMID: 18366728 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.

    Wang LF, Fokas E, Bieker M, Rose F, Rexin P, Zhu Y, Pagenstecher A, Engenhart-Cabillic R, An HX.

    Oncol Rep. 2008 Jan;19(1):151-6.PMID: 18097589 [PubMed - indexed for MEDLINE]Related articles

    3.

    TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.

    Kuijlen JM, Mooij JJ, Platteel I, Hoving EW, van der Graaf WT, Span MM, Hollema H, den Dunnen WF.

    J Neurooncol. 2006 Jun;78(2):161-71. Epub 2006 Mar 17.PMID: 16544055 [PubMed - indexed for MEDLINE]Related articles

    4.

    Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.

    Liang Y, Bollen AW, Aldape KD, Gupta N.

    BMC Cancer. 2006 Apr 19;6:97.PMID: 16623952 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.

    Hutterer M, Knyazev P, Abate A, Reschke M, Maier H, Stefanova N, Knyazeva T, Barbieri V, Reindl M, Muigg A, Kostron H, Stockhammer G, Ullrich A.

    Clin Cancer Res. 2008 Jan 1;14(1):130-8.PMID: 18172262 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme.

    Sminia P, Stoter TR, van der Valk P, Elkhuizen PH, Tadema TM, Kuipers GK, Vandertop WP, Lafleur MV, Slotman BJ.

    J Cancer Res Clin Oncol. 2005 Oct;131(10):653-61. Epub 2005 Oct 20.PMID: 16133570 [PubMed - indexed for MEDLINE]Related articles

    7.

    miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

    Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG.

    BMC Med. 2008 Jun 24;6:14.PMID: 18577219 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM).

    Grunda JM, Nabors LB, Palmer CA, Chhieng DC, Steg A, Mikkelsen T, Diasio RB, Zhang K, Allison D, Grizzle WE, Wang W, Gillespie GY, Johnson MR.

    J Neurooncol. 2006 Dec;80(3):261-74. Epub 2006 Jun 14.PMID: 16773218 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

    Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, Oka K, Ishimaru Y, Ushio Y.

    Cancer Res. 2003 Oct 15;63(20):6962-70.PMID: 14583498 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme.

    Flynn JR, Wang L, Gillespie DL, Stoddard GJ, Reid JK, Owens J, Ellsworth GB, Salzman KL, Kinney AY, Jensen RL.

    Cancer. 2008 Sep 1;113(5):1032-42.PMID: 18618497 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma.

    Wang J, Li G, Ma H, Bao Y, Wang X, Zhou H, Sheng Z, Sugimura H, Jin J, Zhou X.

    Hum Pathol. 2007 Nov;38(11):1649-56. Epub 2007 Jul 31.PMID: 17669470 [PubMed - indexed for MEDLINE]Related articles

    12.

    PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value.

    Reddy PS, Umesh S, Thota B, Tandon A, Pandey P, Hegde AS, Balasubramaniam A, Chandramouli BA, Santosh V, Rao MR, Kondaiah P, Somasundaram K.

    Cancer Biol Ther. 2008 May;7(5):663-8.PMID: 18728403 [PubMed - indexed for MEDLINE]Related articles

    13.

    Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.

    Shi L, Chen XM, Wang L, Zhang L, Chen Z.

    Cancer. 2007 Apr 15;109(8):1523-31.PMID: 17342767 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue.

    Lama G, Mangiola A, Anile C, Sabatino G, De Bonis P, Lauriola L, Giannitelli C, La Torre G, Jhanwar-Uniyal M, Sica G, Maira G.

    Int J Oncol. 2007 Jun;30(6):1333-42.PMID: 17487353 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.

    Nagane M, Kobayashi K, Ohnishi A, Shimizu S, Shiokawa Y.

    Jpn J Clin Oncol. 2007 Dec;37(12):897-906. Epub 2007 Dec 21.PMID: 18156172 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Role of Wnt5a in the proliferation of human glioblastoma cells.

    Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY, Kim KW, Jung JS.

    Cancer Lett. 2007 Nov 18;257(2):172-81. Epub 2007 Aug 20.PMID: 17709179 [PubMed - indexed for MEDLINE]Related articles

    17.

    YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.

    Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, Colman H, Yang H, Ledoux A, Blair H, Passe S, Jenkins RB, Aldape KD.

    Clin Cancer Res. 2005 May 1;11(9):3326-34.PMID: 15867231 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group.

    Chinnaiyan P, Wang M, Rojiani AM, Tofilon PJ, Chakravarti A, Ang KK, Zhang HZ, Hammond E, Curran W Jr, Mehta MP.

    Radiat Oncol. 2008 Sep 25;3:32.PMID: 18817556 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumors.

    Potti A, Forseen SE, Koka VK, Pervez H, Koch M, Fraiman G, Mehdi SA, Levitt R.

    Cancer Invest. 2004;22(4):537-44.PMID: 15565811 [PubMed - indexed for MEDLINE]Related articles

    20.

    Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas.

    Marie SK, Okamoto OK, Uno M, Hasegawa AP, Oba-Shinjo SM, Cohen T, Camargo AA, Kosoy A, Carlotti CG Jr, Toledo S, Moreira-Filho CA, Zago MA, Simpson AJ, Caballero OL.

    Int J Cancer. 2008 Feb 15;122(4):807-15.PMID: 17960622 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity